John E Kerrigan Selected Research

penetratin

9/2018	Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.
2/2014	A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.
8/2013	Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John E Kerrigan Research Topics

Disease

11	Neoplasms (Cancer) 09/2018 - 08/2009
3	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2018 - 08/2013
2	Lung Neoplasms (Lung Cancer) 09/2018 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 09/2018 - 02/2014
2	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2015 - 08/2013
1	Carcinoma (Carcinomatosis) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2013
1	Autoimmune Diseases (Autoimmune Disease) 02/2013
1	Communicable Diseases (Infectious Diseases) 02/2013
1	Osteosarcoma (Osteogenic Sarcoma) 02/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2013
1	Ductal Carcinoma 02/2011
1	Cardiotoxicity 09/2007
1	Infertility (Sterility) 04/2005
1	Hyperthyroidism 04/2005
1	Adenocarcinoma 01/2004
1	Infections 09/2003

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 09/2018 - 09/2007
3	penetratinIBA 09/2018 - 08/2013
3	Peptides (Polypeptides)IBA 09/2018 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2015
3	NucleotidesIBA 11/2016 - 10/2015
2	NADP (NADPH)IBA 11/2016 - 10/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2016 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 08/2013
2	Liposomes (Liposome)IBA 02/2014 - 08/2013
1	Bone Morphogenetic Protein ReceptorsIBA 01/2018
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 11/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2015
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 10/2015
1	EnzymesIBA 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	purineIBA 10/2015
1	pyrimidineIBA 10/2015
1	Protein Kinases (Protein Kinase)IBA 04/2015
1	thionicotinamide adenine dinucleotide phosphateIBA 02/2013
1	NAD kinaseIBA 02/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2013
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 02/2013
1	Estrogen ReceptorsIBA 02/2011
1	ElementsIBA 02/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2007
1	Dexrazoxane (Zinecard)FDA LinkGeneric 09/2007
1	Hormones (Hormone)IBA 04/2005
1	tumor-associated antigen 72IBA 01/2004
1	AntigensIBA 01/2004
1	Phosphates (Orthophosphate)IBA 01/2004
1	2-deoxystreptamineIBA 09/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2003
1	AminoglycosidesIBA 09/2003

Therapy/Procedure

3	Therapeutics 09/2018 - 01/2004
1	Molecular Targeted Therapy 09/2018